Ribavirin in the treatment of SARS: A new trick for an old drug?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

• Publication date

  2003-05-13

• Fields of study

  Medicine

• Identifiers
  PMID 12743076PMCID PMC154189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A major outbreak of severe acute respiratory syndrome in Hong Kong.

  2003cited by this paper
• Identification of severe acute respiratory syndrome in Canada.

  2003cited by this paper
• The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients

  2003cited by this paper
• A cluster of cases of severe acute respiratory syndrome in Hong Kong.

  2003cited by this paper
• Meta‐analysis: ribavirin‐induced haemolytic anaemia in patients with chronic hepatitis C

  2002cited by this paper
• Inhibition of Warfarin Activity by Ribavirin

  2002cited by this paper
• Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection.

  2001cited by this paper
• The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase

  2001cited by this paper
• Adverse effects and other safety aspects of the hepatitis C antivirals

  2000cited by this paper
• Intravenous Ribavirin and Hyperammonemia in an Immunocompromised Patient Infected with Adenovirus

  2000cited by this paper
• The clinical pharmacology of ribavirin.

  1999cited by this paper
• Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance during 1 Year of Open-Label Experience

  1998cited by this paper
• Exposure of pregnant women to ribavirin‐contaminated air: risk assessment and recommendations

  1993cited by this paper
• Ribavirin

  1991cited by this paper
• Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome.

  1991cited by this paper
• A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.

  1991cited by this paper
• National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

  1988cited by this paper

• Pan-viral efficacy profile of ribavirin: quantitative potency and safety landscape across virus families

  2025cites this paper
• How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?

  2024cites this paper
• Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, Zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2

  2023cites this paper
• Ethical issues in Nipah virus control and research: addressing a neglected disease

  2023cites this paper
• Geometry optimization, impact of solvation on the spectral (FT-IR, UV, NMR) analysis, Quantum chemical parameters, and the bioactivity of feruloyltyramine as a potential anti-Lassa virus agent via molecular docking

  2023cites this paper
• QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CLpro inhibitors

  2023cites this paper
• Identification of a potent dual-function inhibitor for hIMPDH isoforms by computer-aided drug discovery approaches

  2022influential citation
• On Analysis of Temperature Based Topological Indices of Some Covid-19 Drugs

  2022cites this paper
• Discovery of compounds inhibiting SARS-COV-2 multi-targets

  2022cites this paper
• Efeito da estimulação elétrica transcutânea do nervo vago na inflamação, modulação autonômica cardíaca e evolução clínica dos pacientes com COVID-19: estudo de protocolo para um ensaio clínico, controlado, randomizado e cego

  2022cites this paper
• Effects of transcutaneous auricular vagus nerve stimulation on inflammation, cardiac autonomic modulation, and clinical evolution of patients with COVID-19: protocol for a clinical, controlled, randomized, and blind trial

  2022cites this paper
• An Overview of the Approaches for the Pharmacotherapy of Pandemic Causing Coronaviruses of the 21st Century

  2022cites this paper
• Lassa fever coinfection with COVID-19 among health care workers: Report of two cases

  2021cites this paper
• Thillaivanan S

  2021cites this paper
• Current Therapeutics and Prophylactics against COVID-19

  2021cites this paper
• Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages

  2021cites this paper
• Exploring Potential Synergism Between Darunavir/Cobicistat and Ribavirin for the Treatment of Covid-19 Patients: A Retrospective Comparison Study

  2021cites this paper
• What if COVID-19 affects the child: which weapons and how to use them.

  2021cites this paper
• A randomized trial in the investigation of anxiety and depression in patients with coronavirus disease 2019 (COVID-19).

  2021cites this paper
• Medicina alternativa para infecciones respiratorias de etiología viral

  2021cites this paper
• Therapeutic Strategies in the Management of COVID-19

  2021cites this paper
• Frequency of Confirmed Corona Infection (COVID-19) in Children in Affected Families of Gujrat

  2021cites this paper
• In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals

  2021cites this paper
• Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review

  2020influential citation
• SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries

  2020cites this paper
• Combating the Coronavirus Pandemic: Early Detection, Medical Treatment, and a Concerted Effort by the Global Community

  2020cites this paper
• Studying the Effectiveness of Ribavirin® in the Experimental Form of Severe Acute Respiratory Syndrome

  2020cites this paper
• Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach

  2020cites this paper
• Current epidemiological and clinical features of COVID-19; a global perspective from China

  2020cites this paper
• The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

  2020influential citation
• Review of trials currently testing treatment and prevention of COVID-19

  2020cites this paper
• Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19

  2020cites this paper
• Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19

  2020cites this paper
• The current understanding and potential therapeutic options to combat COVID-19

  2020cites this paper
• Review and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally.

  2020cites this paper
• Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics

  2020cites this paper
• Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease

  2020cites this paper
• Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019

  2020cites this paper
• Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)

  2020cites this paper
• COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease.

  2020cites this paper
• Immune response and possible therapeutics in COVID-19

  2020cites this paper
• Review and methodological analysis of trials currently testing treatment and prevention options for COVID-19 globally

  2020cites this paper
• THE EPIDEMIOLOGICAL AND CLINICAL FEATURES OF COVID-19 AND LESSONS FROM THIS GLOBAL INFECTIOUS PUBLIC

  2020cites this paper
• Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations

  2020cites this paper
• One year update on the COVID-19 pandemic: Where are we now?

  2020cites this paper
• COVID-19: implications of SARS-CoV-2 in Colombia

  2020cites this paper
• Covid-19 Therapy: What Have We Learned In 8 Months?

  2020cites this paper
• The COVID 19-AN OVERVIEW ON EPIDEMIOLOGY, SYMPTOMS, PREVENTION, MANAGEMENT, TREATMENT AND ROLE OF HEALTH WORKERS

  2020cites this paper
• Lopinavir/ritonavir: is early administration better in Covid-19?

  2020cites this paper
• A Review on Hematologic Malignant Patients Infected with 2019 Novel Coronavirus

  2020cites this paper
• COVID-19 Pandemic: Evidences from Clinical Studies

  2020cites this paper
• A brief review on history, transmission and management of corona virus outbreaks

  2020cites this paper
• A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion

  2020cites this paper
• COVID-19 therapy: What weapons do we bring into battle?

  2020cites this paper
• Nanoformulation-Based Antiviral Combination Therapy for Treatment of COVID-19

  2020cites this paper
• Management of SARS-COV-2; The Missing Link?: A Critical Pharmaco-Immuno-Logical Review

  2020cites this paper
• The recent outbreaks of human coronaviruses: A medicinal chemistry perspective

  2020cites this paper
• COVID-19: implications of SARS-CoV-2 in Colombia.

  2020cites this paper
• COVID-19 Therapeutic Options Under Investigation

  2020cites this paper
• Pharmacotherapy Considerations in CKD Patients With COVID-19, A Narrative Review.

  2020cites this paper
• Therapeutic targets and computational approaches on drug development for COVID-19.

  2020cites this paper
• Polymerases of Coronaviruses

  2018influential citation
• Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

  2018cites this paper
• Polymerases of Coronaviruses: Structure, Function, and Inhibitors

  2018influential citation
• Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice

  2017cites this paper
• Étude de molécules antivirales originales ciblant les fonctions cellulaires et la réponse immunitaire innée

  2016cites this paper
• Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin

  2016influential citation
• An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

  2016cites this paper
• Challenges presented by MERS corona virus, and SARS corona virus to global health

  2016cites this paper
• Ventilation Rates during the Aggregate Daytime Activities of WorkingFemales in Hospitals: Data before their Pregnancy and at their 9th, 22ndand 36th Week of Gestation

  2016cites this paper
• Bioproduction of ribavirin by green microbial biotransformation

  2015cites this paper
• Current concepts in SARS treatment

  2014cites this paper
• What is the future of ribavirin therapy for hepatitis C?

  2014cites this paper
• Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

  2013cites this paper
• Síndrome respiratorio agudo severo (SRAS).

  2013cites this paper
• Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

  2013cites this paper
• Respiratory syncytial virus lower respiratory tract infection in a pediatric liver transplant recipient treated with oral ribavirin

  2012cites this paper
• Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development

  2011cites this paper
• Infectious Respiratory Disease Outbreaks and Pregnancy: Occupational Health and Safety Concerns of Canadian Nurses

  2011cites this paper
• Reverse Genetics System for Mouse Hepatitis Virus Strain 1

  2011cites this paper
• Occupational Hazards for Pregnant Nurses

  2011cites this paper
• Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.

  2009cites this paper
• Randomized, controlled trial of oral ribavirin for Japanese encephalitis in children in Uttar Pradesh, India.

  2009cites this paper
• Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory Syndrome

  2009cites this paper
• Synthesis and affinity to DNA of phenylbenzoimidazoles and benzoimidazo[1,2-c]quinazolines

  2009cites this paper
• [SARS-CoV infection and pregnancy].

  2008influential citation
• Ribavirin targets eIF4E dependent Akt survival signaling.

  2008cites this paper
• The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.

  2008cites this paper
• Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

  2008cites this paper
• Title Treatment of severe acute respiratory syndrome with lopinavir / ritonavir : A multicentre retrospective matched cohort study

  2008cites this paper
• Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy

  2007cites this paper
• Adverse Events Associated with High‐Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome

  2007cites this paper
• Pharmacologic treatment of SARS: current knowledge and recommendations.

  2007cites this paper
• Another Bipartisan Multi-Billion Dollar Medical Boondoggle:

  2006cites this paper
• Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-like proteinase.

  2006cites this paper
• Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin

  2006influential citation
• sars: Are we still at risk?

  2006cites this paper
• Antiviral Activity of Nucleoside Analogues against SARS-coronavirus (SARS-CoV)

  2006cites this paper
• Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice

  2006cites this paper
• PHOTOLABELING PROBES OF RIBAVIRIN AND EICAR

  2005cites this paper